BioAtla, Inc.

NASDAQ:BCAB

0.4964 (USD) • At close February 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -123.462-106.482-95.402-35.853-29.855-28.979
Depreciation & Amortization 1.2211.1991.331.0080.860.794
Deferred Income Tax 00-0.6864.4640.0060
Stock Based Compensation 13.54414.56325.1173.022-0.0060.003
Change In Working Capital 4.680.2877.424-2.49825.102-9.704
Accounts Receivables 000000
Inventory 000000
Accounts Payables 5.28407.992-1.663.130.446
Other Working Capital -0.6040.287-0.568-0.83821.972-10.15
Other Non Cash Items 0.0020.0130.003-6.477-5.7522.572
Operating Cash Flow -104.015-90.42-62.214-36.334-9.645-35.317
Investing Activities:
Investments In Property Plant And Equipment -0.098-0.268-0.924-0.59-1.509-0.988
Acquisitions Net 00.0030-0.019-0.0050.019
Purchases Of Investments 000000
Sales Maturities Of Investments 000000
Other Investing Activites 00-0.9240.0190.0050
Investing Cash Flow -0.098-0.265-0.924-0.59-1.509-0.988
Financing Activities:
Debt Repayment 0003.43245
Common Stock Issued 0.33661.68270.994200.22900
Common Stock Repurchased -000000
Dividends Paid 000000
Other Financing Activities 0.077-0.469-1.48268.164-0.0050.019
Financing Cash Flow 0.0770.06169.512271.8253.9955.019
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -104.036-29.4726.374234.901-7.159-31.286
Cash At End Of Period 111.471215.507244.979238.6053.70410.863